Researches has shown that estrogen can upregulate osteopontin (OPN) expression and promote lung cancer cell migration and growth by activating the MEK/ERK signaling pathway through Estrogen Receptor Beta (ERβ) (23, 24). Here, ESR2 is linked to lung carcinoma.